IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer Maria HenningsonMaria HietalaHelena Jernström OriginalPaper 28 November 2010 Pages: 173 - 185
Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53 Alessandra FerrariniAgnes Auteri-KaczmarekChristian Monnerat BriefCommunication 12 January 2011 Pages: 187 - 192
A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges Molly S. DanielsJennifer K. BurzawaKaren H. Lu OriginalPaper 19 January 2011 Pages: 193 - 197
Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study Sook-Yee YoonMeow-Keong ThongSoo-Hwang Teo OriginalPaper 12 February 2011 Pages: 199 - 205
Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations Thomas v. O. HansenLars JønsonFinn C. Nielsen BriefCommunication 12 February 2011 Pages: 207 - 212
BRCA1/2 genetic testing uptake and psychosocial outcomes in men Kristi D. GravesRhoda GatammahMarc D. Schwartz OriginalPaper 02 March 2011 Pages: 213 - 223
PALB2 mutations in familial breast and pancreatic cancer Erin W. HofstatterSusan M. DomchekNadine Tung OriginalPaper 02 March 2011 Pages: 225 - 231
A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer Ava KwongEnders K. O. NgJames M. Ford BriefCommunication Open access 15 March 2011 Pages: 233 - 237
Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer Anna Isinger-EkstrandChristina TherkildsenMef Nilbert BriefCommunication 05 December 2010 Pages: 239 - 243
Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome) Aedan RobertsDerek NancarrowJoanne P. Young OriginalPaper Open access 17 December 2010 Pages: 245 - 254
Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report Matjaz VogelsangRadovan Komel OriginalPaper 07 December 2010 Pages: 255 - 263
Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome V. Medina-AranaL. DelgadoA. M. Fernández-Peralta OriginalPaper 12 January 2011 Pages: 265 - 271
Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies Karin HardtSven Boris HeickBrigitte Royer-Pokora OriginalPaper 15 March 2011 Pages: 273 - 284
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation Patrizia LastellaMargherita PatrunoAlessandro Stella OriginalPaper 01 February 2011 Pages: 285 - 295
Mutation deep within an intron of MSH2 causes Lynch syndrome Mark ClendenningDaniel D. BuchananJoanne P. Young OriginalPaper 01 March 2011 Pages: 297 - 301
Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study Kui HuangLia P. GutierrezJames M. Church OriginalPaper 26 February 2011 Pages: 303 - 308
A new phenotypic manifestation of familial adenomatous polyposis Daniel L. EdelsteinFrancis M. GiardielloJessica C. Ramella-Roman OriginalPaper 10 March 2011 Pages: 309 - 313
Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma N. SabbaghianR. KyleM. Tischkowitz BriefCommunication 11 December 2010 Pages: 315 - 317
Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition Mohamed H. Abdel-RahmanRobert PilarskiFrederick H. Davidorf BriefCommunication 12 November 2010 Pages: 319 - 321
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience Ralph SchneiderEmily P. SlaterDetlef K. Bartsch OriginalPaper 05 January 2011 Pages: 323 - 330
The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer Ning LiKang ShaoJie He OriginalPaper 21 November 2010 Pages: 331 - 336
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma Ingrid SladeAnne MurrayNazneen Rahman OriginalPaper 28 December 2010 Pages: 337 - 342
A new frameshift MEN1 gene mutation associated with familial malignant insulinomas Shirin Hasani-RanjbarMahsa M. AmoliBagher Larijani OriginalPaper 24 December 2010 Pages: 343 - 348
Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family L. McKayM. FrydenbergI. Winship BriefCommunication 29 December 2010 Pages: 349 - 353
Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma Erik F. HensenJean-Pierre Bayley OriginalPaper Open access 17 November 2010 Pages: 355 - 363
Novel germline SDHD mutation: diagnosis and implications to the patient Jeena VargheseMontserrat Ayala-RamirezCamilo Jimenez OriginalPaper 12 February 2011 Pages: 365 - 371
The impact of cancer pathology confirmation on clinical management of a family history of cancer E. EdwardsA. Lucassen OriginalPaper 07 December 2010 Pages: 373 - 380
Impact of computer-assisted data collection, evaluation and management on the cancer genetic counselor’s time providing patient care Stephanie A. CohenDawn E. McIlvried OriginalPaper 15 January 2011 Pages: 381 - 389
Familial gastric cancer: update for practice management Giovanni CorsoDaniele MarrelliFranco Roviello OriginalPaper 24 December 2010 Pages: 391 - 396
Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics Heli J. Lehtonen OriginalPaper 15 March 2011 Pages: 397 - 411
